Seattle, WA | October 12, 2018
Split Biosciences, a Seattle based single-cell analysis company, today announced the recent completion of its seed financing.
Split Biosciences is a University of Washington spinout and will use the financing to build upon the groundbreaking single-cell RNA-sequencing technology–SPLiT-seq–published in Science in early 2018. The technology addresses current limitations of single-cell RNA-sequencing through the use of multiple rounds of in-situ combinatorial barc
